SPXC.NYSESpx Technologies, INC
Form 4: SPX Technologies CEO Eugene Joseph Lowe III Reports Stock Transactions and Updates Power of Attorney
Sentiment:
SEC Form 4 Filing
Eugene Joseph Lowe III, CEO of SPX Technologies, reports acquisition and disposal of common stock related to performance-based compensation and tax obligations, while also updating his power of attorney for SEC filings.
Summary
- Eugene Joseph Lowe III, the President and CEO of SPX Technologies, filed a Form 4 detailing changes in his beneficial ownership of SPXC stock on February 24, 2025.
- He acquired 19,490 shares of common stock related to the achievement of performance goals under the SPX 2019 Stock Compensation Plan for the 2022-2025 performance period.
- He disposed of 30,213 shares to cover withholding taxes associated with the vesting of restricted stock units at a price of $140.3 per share.
- Following these transactions, Lowe directly owns 656,322 shares of SPXC common stock and indirectly owns 5,005 shares through a 401(k) plan.
- The filing also includes details of Lowe's holdings of employee stock options with various exercise prices and expiration dates.
- Additionally, Lowe updated his Limited Power of Attorney, appointing Chere H. Johnson, Caroline Prescott, and Coleman Wombwell to handle SEC filings related to his SPXC securities ownership.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing primarily reflects routine transactions related to executive compensation. The acquisition of shares due to performance is mildly positive, while the disposal for tax purposes is neutral.
Positives
- The acquisition of shares reflects the achievement of performance goals, which could be seen as a positive indicator of company performance.
- The continued holding of a significant number of shares and stock options demonstrates the CEO's vested interest in the company's success.
Negatives
- The disposal of shares to cover withholding taxes, while a normal occurrence, does reduce the CEO's direct shareholding.
Risks
- The value of the stock options is dependent on the future performance of SPX Technologies' stock price.
- Changes in tax laws could impact the attractiveness of stock-based compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are standard practice among publicly traded companies like SPX Technologies.
- The vesting schedules and performance-based grants are typical mechanisms used to align executive incentives with shareholder value.
- Comparing the size of Lowe's holdings and option grants to those of CEOs at similarly sized industrial companies (e.g., ITT Inc., Roper Technologies) would provide a benchmark for assessing the magnitude of his equity stake.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they reflect the CEO's compensation and tax obligations.
- Employees may be indirectly impacted by the performance-based compensation, as it aligns executive incentives with company goals.
Key Dates
| Date | Description |
|---|---|
| 03/02/2019 | Date of employee stock option grant with exercise price of $12.85, vesting in three equal installments beginning on March 2, 2017. |
| 03/01/2020 | Date of employee stock option grant with exercise price of $27.4, vesting in three equal installments beginning on March 1, 2018. |
| 02/22/2021 | Date of employee stock option grant with exercise price of $32.69, vesting in three equal installments beginning on February 22, 2019 |
| 02/21/2022 | Date of employee stock option grant with exercise price of $36.51, vesting in three equal installments beginning on February 21, 2020. |
| 02/20/2023 | Date of employee stock option grant with exercise price of $50.09, vesting in three equal installments beginning on February 20, 2021. |
| 08/27/2024 | Date of execution of the Limited Power of Attorney. |
| 03/01/2024 | Date of employee stock option grant with exercise price of $58.34, vesting in three equal installments beginning on March 1, 2022. |
| 03/01/2025 | Date of employee stock option grant with exercise price of $48.97, vesting in three equal installments beginning on March 1, 2023. |
| 02/24/2025 | Date of the reported transactions: acquisition and disposal of common stock. |
| 02/26/2025 | Date of signature on the Form 4 filing. |
| 03/01/2026 | Date of employee stock option grant with exercise price of $71.93, vesting in three equal installments beginning on March 1, 2024. |
| 02/28/2027 | Date of employee stock option grant with exercise price of $116.4, vesting in three equal installments beginning on February 28, 2025. |
| 03/02/2026 | Expiration date of employee stock option to purchase common stock with exercise price of $12.85. |
| 03/01/2027 | Expiration date of employee stock option to purchase common stock with exercise price of $27.4. |
| 02/22/2028 | Expiration date of employee stock option to purchase common stock with exercise price of $32.69. |
| 02/21/2029 | Expiration date of employee stock option to purchase common stock with exercise price of $36.51. |
| 02/20/2030 | Expiration date of employee stock option to purchase common stock with exercise price of $50.09. |
| 03/01/2031 | Expiration date of employee stock option to purchase common stock with exercise price of $58.34. |
| 03/01/2032 | Expiration date of employee stock option to purchase common stock with exercise price of $48.97. |
| 03/01/2033 | Expiration date of employee stock option to purchase common stock with exercise price of $71.93. |
| 02/28/2034 | Expiration date of employee stock option to purchase common stock with exercise price of $116.4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.